Contact ROS1, TAS2R50, ZNF627, MIAF3 genes and 16q23.1, 6p24, 9p21 chromosomal regions with myocardial infarction in Caucasians of Novosibirsk in two age groups

Aim: Investigate relations of 8 SNPs with myocardial infarction in groups of up to 55 years and after 55 years. Methods: The group of patients with myocardial infarction, arrived in the intensive care unit City Clinical Hospital № 1 (2009-2010 gg.) 160 people (113 men and 47 women). The control group was formed based on the sample of population 45-69 year old residents of the October and the Kirov district of Novosibirsk (9.400 people), which was collected by Institute of Internal Medicine SB RAMS during the work on the international project HAPIEE (Health, Alcohol and Psychosocial factors In Eastern Europe). It included 420 people with no signs of myocardial infarction (men 270, women 150). Genomic DNA was isolated from venous blood by phenol-chloroform extraction. SNP of gene were tested by RT-PCR according to the protocol of the manufacturer (TaqMan Probes, Applied Biosystems, USA) on the device ABI 7900HT. In a study following SNPs were taken: rs499818, rs619203, rs1333049, rs1376251, rs2549513, rs4804611, rs17465637. Results: For rs1333049 were shown an association with MI: SS OR = 2.05 (95 % CI 1.35-3.12 p = 0.001, CC vs CT + TT) and PT OR = 0.59 (95 % CI 0.37-0.93; p = 0.023; CT vs CC + TT) in the group. In both age groups, an association has been confirmed: SS OR = 2.92 (95 % CI 1.39-6.16; p = 0.006; CC vs CT + TT) for junior and SS OR = 1.77 (95 % CI 1.05-2.97; p = 0.035; CC vs CT + TT) and senior groups. For rs4804611 shows a predisposing role in relation to MI AA OR = 1.63 (95 % CI, 1.03-2.45; P = 0.04; AA vs AG + GG) in the older age group, for the remaining SNPs statistically valid data has been received. Conclusions: Thus in this study were confirmed by rs1333049 association (hr. 9) with myocardial infarction, regardless of age, as well as shows the association of rs4804611 in the group over 55 years.

rs1333049, rs4804611, myocardial infarction, SNP, rs1333049, rs4804611

1. Оганов Р.Г., Масленникова Г.Я. Демографические тенденции в Российской Федерации: вклад болезней системы кровообращения. Кардиоваскулярная терапия и профилактика. 2012. Т. 11, № 1. С. 5-10.

2. Гафаров В.В., Громова Е.А., Гафарова А.В. и др. Инфаркт миокарда и стресс на работе и в семье: 10-летний риск возникновения в открытой популяции мужчин 25-64 лет (эпидемиологическое исследование в рамках программы ВОЗ «MONICA-PSYCHOSOCIAL») // Кардиология. 2011. № 3. С. 10-16.

3. Incalcaterra E., Hoffmann E., Averna M.R., Caimi G. Genetic risk factors in myocardial infarction at young age // Minerva Cardioangiol. 2004. Vol. 52, N 4. P. 287-312.

4. Смит К., Калко С., Кантор Ч. Пульс-электрофорез и методы работы с большими молекулами ДНК // Анализ генома / под ред. К. Дейвиса, пер. с англ. М.: Мир, 1990. С. 58-94.

5. González P., Alvarez R., Batalla A. et al. Genetic variation at the chemokine receptors CCR5/CCR2 in myocardial infarction // Genes Immun. 2001. Jun. Vol. 2, N 4. P. 191-195.

6. Samani N.J., Erdmann J., Hall A.S. et al. Genomewide association analysis of coronary artery disease // N. Engl. J. Med. 2007. Vol. 2357. P. 443-453.

7. Hiura Y., Fukushima Y., Yuno M. et al. Validation of the association of genetic variants on chromosome 9p21 and 1q41 with myocardial infarction in a Japanese population // Circ. J. 2008. Aug. Vol. 72, N 8. P. 1213-1217.

8. Myocardial Infarction Genetics Consortium Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants // Nat. Genet. 2009. Mar. Vol. 41, N 3. P. 334-341.

9. He Q.C., Hu Y.Y., Zhang Q.P. et al. A meta-analysis of three identified single nucleotide polymorphisms at 1p13.3 and 1q41 and their associations with lipid levels and coronary artery disease // Kaohsiung J. Med. Sci. 2017. Jan. Vol. 33, N 1. P. 1-10.

10. Li X., Huang Y., Yin D. Meta-analysis identifies robust association between SNP rs17465637 in MIA3 on chromosome 1q41 and coronary artery disease // Atherosclerosis. 2013. Nov. Vol. 231, N 1. P. 136-140.

11. Bressler J., Folsom A.R., Couper D.J. et al. Genetic variants identified in a European genome-wide association study that were found to predict incident coronary heart disease in the atherosclerosis risk in communities study // Am. J. Epidemiol. 2010. Jan. 1; Vol. 171, N 1. P. 14-23.

12. Haver V.G., Verweij N., Kjekshus J. The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA) // BMC Med. Genet. 2014. Dec. Vol. 21, N 15. P. 140.

13. Shahid S.U., Shabana, Cooper J.A. Genetic risk analysis of coronary artery disease in Pakistani subjects using a genetic risk score of 21 variants // Atherosclerosis. 2017. Jan. 22. Vol. 258. P. 1-7.

14. Орлов П.С., Максимов В.Н., Гафаров В.В. и др. Проверка 8 ОНП на пригодность в качестве маркеров риска развития инфаркта миокарда у жителей Новосибирска // Атеросклероз. 2015. Т. 11, № 1. С. 14-19.

15. Куликов И.В., Ложкина Н.Г., Максимов В.Н и др. Генетические маркеры тяжести поражения коронарных сосудов у больных с острым коронарным синдромом // Бюл. СО РАМН. 2013. № 4. С. 65-70.

16. Максимов В.Н., Куликов И.В., Орлов П.С. и др. Проверка взаимосвязи между девятью однонуклеотидными полиморфизмами и инфарктом миокарда на сибирской популяции // Вестн. РАМН. 2012. № 5. С. 24-29.

17. Шестерня П.А., Никулина С.Ю., Шульман В.А и др. Генетические предикторы инфаркта миокарда у лиц молодого возраста // Кардиология. 2013. № 7. С. 4-8.

18. Theodoraki E.V., Nikopensius T., Suhorutsenko J. et al. ROS1 Asp2213Asn polymorphism is not associated with coronary artery disease in a Greek case-control study // Clin. Chem. Lab. Med. 2009. Vol. 47, N 12. P. 1471-1443.

19. Ellis K.L., Pilbrow A.P., Frampton C.M. et al. A Common Variant at Chromosome 9P21.3 Is Associated with Age of Onset of Coronary Disease but Not Subsequent Mortality // Circ. Cardiovasc. Genet. 2010. Vol. 3, N 3. P. 286-293.

20. Horne B.D., Carlquist J.F., Muhlestein J.B. et al. Associations with myocardial infarction of six polymorphisms selected from a three-stage genome-wide association study // Am. Heart J. 2007. Nov. Vol. 154, N 5. P. 969-975.

21. Shiffman D., Ellis S.G., Rowland C.M. et al. Identification of four gene variants associated with myocardial infarction // Am. J. Hum. Genet. 2005. Vol. 77. P. 596-605.

22. Yamada Y., Kato K., Oguri M. et al. Genetic risk for myocardial infarction determined by polymorphisms of candidate genes in a Japanese population // J. Med. Genet. 2008. Apr. Vol. 45, N 4. P. 216-221.

23. Larson M.G., Atwood L.D., Benjamin E.J. et al. Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes // BMC Med. Genet. 2007. Sep. Vol. 19, N 8. Suppl. 1. P. S5.

24. Schembre S.M., Cheng I., Wilkens L.R. et al. Variations in bitter-taste receptor genes, dietary intake, and colorectal adenoma risk // Nutr. Cancer. 2013. Vol. 65, N 7. P. 982-990.

25. Buysschaert I., Carruthers K.F., Dunbar D.R. et al. A variant at chromosome 9p21 is associated with recurrent myocardial infarction and cardiac death after acute coronary syndrome: The GRACE Genetics Study // Eur. Heart J. 2010. Vol. 31, N 9. P. 1132-1141.

26. Goncharova I.A., Makeeva O.A., Golubenko M.V. Genes for Fibrogenesis in the Determination of Susceptibility to Myocardial Infarction // Mol. Biol. (Mosk). 2016. Jan-Feb. Vol. 50, N 1. P. 94-105.